Le Lézard
Classified in: Health, Business, Covid-19 virus
Subject: PDT

The Greeley Company Now Offering Chief Medical Officers On-Call


BOSTON, March 30, 2020 /PRNewswire/ -- The Greeley Company, a leader in healthcare consulting, education, external peer review and interim staffing solutions, announces today that its interim staffing division is offering Chief Medical Officer (CMO) On-Call staffing. As COVID-19 presents unprecedented challenges to the healthcare industry, this offering allows hospitals and health systems to access a CMO's experience remotely for just-in-time clinical leadership.

The current COVID-19 outbreak has put tremendous strain on hospitals and healthcare workers. Many hospitals could benefit from additional leadership, but simply don't have the means or the bandwidth to hire key physician executives amid this crisis. Greeley's CMOs will assist in accordance with the needs of the organization, providing clinical leadership in time-sensitive situations needed to respond to COVID-19, such as managing medical staff, spearheading innovation and change, and providing outside expertise.

"As COVID-19 continues to unfold, Greeley is committed to providing the right resources for healthcare organizations, when and where you need them," says Greeley President, Steve Bryant. "By working with a Greeley CMO, hospitals can expand their capacity to address COVID-19-related challenges and deliver on their critical role in combatting this public health crisis."

To learn more about The Greeley Company's CMO On-Call solution, please call 888.749.3054 or email [email protected].

About Greeley

The Greeley Company is a leading provider of consulting, education, interim staffing, credentialing management, and external peer review to healthcare organizations nationwide. Headquartered in the greater Boston area, The Greeley Company has helped more than 1,000 healthcare organizations within the past three years address challenges related to regulatory compliance, credentialing and privileging, peer reviews, clinician burnout, bylaws and physician-hospital alignment. The Greeley Company is a part of The Chartis Group, which provides comprehensive advisory and analytics services to the healthcare industry. For more information, please visit www.greeley.com.

SOURCE The Greeley Company


These press releases may also interest you

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...

at 17:05
Sirona Biochem Corp. ("Sirona") announces the voting results from its Annual General Meeting of Shareholders (the "Meeting"), held in Vancouver, British Columbia on March 28, 2024. The total number of shares represented by shareholders present in...



News published on and distributed by: